Rafferty Asset Management, LLC Akebia Therapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.32 - $0.67 $224,847 - $470,773	-702,647 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.72 - $2.93 $25,508 - $103,804	-35,428 Reduced 4.8%	702,647 $504,000
Q4 2021 Feb 10, 2022	BUY	$2.26 - $3.34 $144,947 - $214,214	64,136 Added 9.52%	738,075 $1.67 Million
Q3 2021 Nov 10, 2021	BUY	$2.35 - $3.88 $185,633 - $306,492	78,993 Added 13.28%	673,939 $1.94 Million
Q2 2021 Aug 10, 2021	SELL	$2.83 - $4.2 $928,262 - $1.38 Million	-328,008 Reduced 35.54%	594,946 $2.26 Million
Q1 2021 May 10, 2021	BUY	$2.92 - $5.06 $1.84 Million - $3.18 Million	628,925 Added 213.9%	922,954 $3.12 Million
Q4 2020 Feb 10, 2021	SELL	$2.22 - $3.78 $488,859 - $832,382	-220,207 Reduced 42.82%	294,029 $823,000
Q3 2020 Nov 13, 2020	BUY	$2.39 - $13.08 $1.13 Million - $6.17 Million	471,362 Added 1099.41%	514,236 $1.29 Million
Q2 2020 Aug 07, 2020	BUY	$6.67 - $13.58 $285,969 - $582,228	42,874 New	42,874 $582,000
Q1 2020 May 15, 2020	SELL	$4.1 - $10.24 $234,224 - $584,990	-57,128 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$3.16 - $6.73 $245,494 - $522,840	-77,688 Reduced 57.63%	57,128 $361,000
Q3 2019 Nov 14, 2019	SELL	$3.55 - $5.4 $586,158 - $891,621	-165,115 Reduced 55.05%	134,816 $528,000
Q2 2019 Aug 09, 2019	BUY	$4.1 - $8.05 $715,613 - $1.41 Million	174,540 Added 139.2%	299,931 $1.45 Million
Q1 2019 May 15, 2019	BUY	$5.41 - $8.73 $678,365 - $1.09 Million	125,391 New	125,391 $1.03 Million

120

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $338M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.